SAC Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-121,242
Closed -$32.1M 209
2014
Q1
$32.1M Sell
121,242
-112,524
-48% -$29.8M 0.17% 154
2013
Q4
$84.9M Buy
233,766
+134,453
+135% +$48.8M 0.49% 43
2013
Q3
$52.8M Sell
99,313
-167,354
-63% -$88.9M 0.29% 85
2013
Q2
$62.4M Buy
+266,667
New +$62.4M 0.34% 68